Outcome of colorectal cancer patients treated with combination bevacizumab therapy: a pooled retrospective analysis of three European cohorts from the angiopredict initiative
Background/Aims: This study is aimed at analyzing the survival rates and prognostic factors of stage IV colorectal cancer patients from 3 European cohorts undergoing combination chemotherapy with bevacizumab. Methods: Progression free-survival (PFS) and overall survival (OS) were analyzed in 172 pat...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
October 19, 2016
|
| In: |
Digestion
Year: 2016, Jahrgang: 94, Heft: 3, Pages: 129-137 |
| ISSN: | 1421-9867 |
| DOI: | 10.1159/000449412 |
| Online-Zugang: | Verlag, Volltext: http://dx.doi.org/10.1159/000449412 Verlag, Volltext: https://www-karger-com.ezproxy.medma.uni-heidelberg.de/Article/FullText/449412 |
| Verfasserangaben: | Johannes Betge, Ana Barat, Verena Murphy, Thomas Hielscher, Nicole C. Van Grieken, Sebastian Belle, Tianzuo Zhan, Nicolai Härtel, Melanie Kripp, Orna Bacon, Martijn Cordes, Elaine W. Kay, Henk M. W. Verheul, Maarten Neerincx, Bryan Hennessy, Ralf D. Hofheinz, Timo Gaiser, Bauke Ylstra, Jochen H. M. Prehn, Diether Lambrechts, Annette T. Byrne, Matthias P. Ebert, Nadine Schulte |
Search Result 1
Outcome of colorectal cancer patients treated with combination bevacizumab therapy: a pooled retrospective analysis of three European cohorts from the Angiopredict initiative
Universitätsbibliothek Heidelberg 2016
Article (Journal)
Book/Monograph
Online Resource